Weiguang Biological: Disclosure of the reply to the specific object issuance stock inquiry letter and document update.

Wego Biology announced that the company has received an inquiry letter from the Shenzhen Stock Exchange, and together with the intermediary agency, they will provide detailed explanations and updates to the prospectus and other application documents. Since the third quarter report of 2025 has been disclosed, the financial data and other related information in the application documents have also been updated accordingly, and the relevant documents were disclosed on the same day on Juchao Information Network. The issuance of A shares to specific investors requires approval from the Shenzhen Stock Exchange and registration approval from the China Securities Regulatory Commission. The final outcome and timeline are uncertain, and the company will promptly disclose any progress.